Our Science – Cheng Website
Sheue-yann Cheng, Ph.D.
Selected Publications |
 |
| 1)
Fozzatti L, Kim DW, Park JW, Willingham MC, Hollenberg AN, Cheng SY. Nuclear receptor corepressor (NCOR1) regulates in vivo actions of a mutated thyroid hormone receptor a. Proc. Natl. Acad. Sci. U.S.A. 2013. [Journal] |
|
| 2)
Kim WG, Zhu X, Kim DW, Zhang L, Kebebew E, Cheng S. Reactivation of the silenced thyroid hormone receptor beta gene expression delays thyroid tumor progression. Endocrinology. 154: 25-35, 2013. [Journal] |
|
| 3)
Blank M, Tang Y, Yamashita M, Burkett SS, Cheng SY, Zhang YE. A tumor suppressor function of Smurf2 associated with controlling chromatin landscape and genome stability through RNF20. Nat. Med. 18: 227-34, 2012. [Journal] |
|
| 4)
Ward Y, Lake R, Martin PL, Killian K, Salerno P, Wang T, Meltzer P, Merino M, Cheng S, Santoro M, Garcia-Rostan G, Kelly K. CD97 amplifies LPA receptor signaling and promotes thyroid cancer progression in a mouse model. Oncogene. [Epub ahead of print], 2012. [Journal] |
|
| 5)
Zhao L, Zhu X, Won Park J, Fozzatti L, Willingham M, Cheng S. Role of TSH in the spontaneous development of asymmetrical thyroid carcinoma in mice with a targeted mutation in a single allele of the thyroid hormone-beta receptor. Endocrinology. 153: 5090-100, 2012. [Journal] |
|
| 6)
Kim DW, Zhao L, Hanover J, Willingham M, Cheng S. Thyroid hormone receptor beta suppresses SV40-mediated tumorigenesis via novel nongenomic actions. Am J Cancer Res. 2: 606-19, 2012. [Journal] |
|
| 7)
Lu C, Zhu X, Willingham MC, Cheng SY. Activation of tumor cell proliferation by thyroid hormone in a mouse model of follicular thyroid carcinoma. Oncogene. 31: 2007-16, 2012. [Journal] |
|
| 8)
O'Shea PJ, Kim DW, Logan JG, Davis S, Walker RL, Meltzer PS, Cheng S, Williams GR. Advanced Bone Formation in Mice with a Dominant-negative Mutation in the Thyroid Hormone Receptor Beta Gene due to Activation of Wnt/beta-Catenin Protein Signaling. J. Biol. Chem. 287: 17812-22, 2012. [Journal] |
|
| 9)
Zhu X, Cheng SY. Modeling follicular thyroid cancer for future therapies. Am J Cancer Res. 2: 130-40, 2012. [Journal] |
|
| 10)
Kim WG, Guigon CJ, Fozzatti L, Park JW, Lu C, Willingham MC, Cheng SY. SKI-606, an Src inhibitor, reduces tumor growth, invasion, and distant metastasis in a mouse model of thyroid cancer. Clin. Cancer Res. 18: 1281-90, 2012. [Journal] |
|
| Click Here to View Expanded Bibliography. |
This page was last updated on 5/6/2013.
